Categories for New R&D

Blog

Newly Published: Can WIN 18,446 function as a nonhormonal female contraceptive? 
Newly Published: Can WIN 18,446 function as a nonhormonal female contraceptive?  Vitamin A deficient women produce less retinoic acid, ... Read full article
Blog

Vaginal Ring Dose-Finding Results Published
Contraceptive vaginal rings (CVRs) offer women a self-controlled, non-daily delivery system. One CVR - the FDA approved NuvaRing® - is on the market, and another, the one-year Ne... Read full article
Blog

NIH Announces Funding for Novel Contraceptive Methods
The National Institutes of Health has released a new funding solicitation to support the development of novel nonsteroidal contrac... Read full article
Blog

Contraceptive Technology Innovation: A Wise Investment
As long as women and men find current family planning methods unacceptable, unaffordable, or inaccessible, there will be a need for contraceptive technology innovation. A job easier said than done. Reproductive physiology is complex, and contraceptiv... Read full article
Blog

Contraceptive Technology Innovation: It’s Everyone’s Business
Guest blog contributors are Julia Bunting, OBE, President of the Population Council, and Laneta Dorflinger, PhD, Director of Contraceptive Technology Innovation at FHI 360. Their two organizations are long-time leaders in the field, bringing ... Read full article
Blog

Ferring Pharmaceuticals to Issue Biomarker Research Grants
Applications for Ferring Pharmaceuticals’ Innovation Grants Program are open until June 11th.  Non-renewable awards of $50,000 to $100,000 are available to support researc... Read full article
Blog

Getting Behind Human-Centered Design for Contraceptive Innovation
Guest blog contributors are Anna Lawton, Global Health Research Associate at FHI 360 and Babitha George,  a partner at Quicksand, a design firm based in India.
When it comes to female contraceptive products, innovation has been mo... Read full article
Blog

Blocking Sperm by Reinforcing Cervical Mucus
Guest blogger is Frederik Petursson Madsen, chief executive officer of Circle Biomedical, with contributions from Thomas Crouzier, group leader at KTH Royal Institute of Technology in Stockholm, Sweden.
Over the past several decade... Read full article
Blog

Daré Bioscience & Orbis Biosciences to Collaborate on Injectables